Results 41 to 50 of about 167,867,171 (233)
Recurrent Giant cell tumour in distal Humerus: A Case report
Introduction: Giant cell tumour of bone (GCT) is a common benign primary bone tumour, seen commonly in the distal Femur, proximal Tibia and distal Radius. Very few cases of GCT are reported in distal humerus.
Y Bhanu Rekha, Y Poornachandra Rao
doaj +1 more source
Malignant Giant-Cell Tumour of Bone
Summary The malignant giant cell tumour of bone is described here as the malignant growth which contains many foreign body giant cells (osteoclasts). This tumour is at first localized to one part of a bone, radiologically shows characteristic trabeculation and histologically shows a structure closely resembling that of the benign giant cell tumour ...
openaire +2 more sources
Clinical periodontal diagnosis
Abstract Periodontal diseases include pathological conditions elicited by the presence of bacterial biofilms leading to a host response. In the diagnostic process, clinical signs such as bleeding on probing, development of periodontal pockets and gingival recessions, furcation involvement and presence of radiographic bone loss should be assessed prior ...
Giovanni E. Salvi +5 more
wiley +1 more source
Effects of Thermoablation with or without Caffeine on Giant Cell Tumour of Bone
Purpose. To evaluate the effect of caffeine on the apoptosis rate of giant cell tumour of bone cells during thermoablation. Methods. Giant cell tumour of bone tissue (2 cm 3 ) was collected from 10 patients. Cells were incubated at 37°C, 40°C, 45°C, 50°C,
Rapin Pimolsanti +4 more
doaj +1 more source
Sporadic giant cell granulomas (GCGs) of the jaws and cherubism‐associated giant cell lesions share histopathological features and microscopic diagnosis alone can be challenging.
Letícia Martins Guimarães +7 more
doaj +1 more source
Advanced Materials for Biologics Delivery to Brain Tumors
Material innovation is central to unlocking the therapeutic potential of biologics against many central nervous system diseases, including brain cancer. By engineering carriers with controlled transport, targeting, and release properties, advanced materials can overcome the blood–brain barrier and tumor microenvironment, improving the delivery of ...
Yuran Feng +4 more
wiley +1 more source
Giant cell tumour of the bone (GCT) is a rare locally aggressive primary bone tumour with an incidence of 3% to 5% of all primary bone tumours. The most common location for this tumour is the long bone metaepiphysis especially of the distal femur ...
Elango Mariappan +2 more
doaj +1 more source
Giant cell tumor (GCT) account around 5% of bone tumors with a slight female preponderance. We are presenting a case 32yr old gentleman, who presented with c/o swelling present on lateral aspect of proximal third of left leg for past one year ...
Sakthikesavan sivanandan +3 more
doaj +1 more source
A very rare case of metachronous multicentric giant cell tumor of bone with benign lung metastasis in form of a very large mass lesion [PDF]
Giant cell tumour (GCT) is a benign, locally aggressive tumour of the bone that accounts for 5% of primary bone tumours and 21% of benign bone tumours. This tumour more commonly presents as a single (solitary) lesion; however, it may appear with multiple
Shekhar Gangadhar Kadam +5 more
doaj +1 more source
Scheme of the KLF9/WTAP/YTHDF2/m6A/CSF1R regulatory axis in osteoclastogenesis and estrogen‐deficient osteoporosis. WTAP‐mediated m6A modification of Csf1r mRNA governs osteoclastogenesis via a YTHDF2‐mediated pathway. Pathological upregulation of KLF9 drives Wtap transcription, leading to increased m6A deposition on the 3’‐UTR of Csf1r mRNA.
Chen Shen +14 more
wiley +1 more source

